Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Its lead single-use nasal dry powder device now available for commercial partnerships
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
CheManager, 20 October 2020
Commitment to partnership and joint innovation for cell and gene therapies
Silicon Republic, October 2, 2020
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Pharmaceutical Technology, 2 Junho 2021
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
High Performance, High-Dose Capsule DPI.